Third Harmonic Bio Statistics
Total Valuation
THRD has a market cap or net worth of $545.04 million. The enterprise value is $285.53 million.
| Market Cap | 545.04M |
| Enterprise Value | 285.53M |
Important Dates
The last earnings date was Wednesday, May 15, 2024, before market open.
| Earnings Date | May 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
THRD has 40.95 million shares outstanding. The number of shares has increased by 1.96% in one year.
| Shares Outstanding | 40.95M |
| Shares Change (YoY) | +1.96% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | 9.95% |
| Owned by Institutions (%) | 92.70% |
| Float | 9.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.07 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 66.10, with a Debt / Equity ratio of 0.01.
| Current Ratio | 66.10 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -10.90% and return on invested capital (ROIC) is -16.18%.
| Return on Equity (ROE) | -10.90% |
| Return on Assets (ROA) | -10.60% |
| Return on Capital (ROIC) | -16.18% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$954,677 |
| Employee Count | 31 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +177.87% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | +177.87% |
| 50-Day Moving Average | 11.64 |
| 200-Day Moving Average | 9.10 |
| Relative Strength Index (RSI) | 53.87 |
| Average Volume (30 Days) | 149,825 |
Short Selling Information
The latest short interest is 1.06 million, so 2.60% of the outstanding shares have been sold short.
| Short Interest | 1.06M |
| Short Previous Month | 2.05M |
| Short % of Shares Out | 2.60% |
| Short % of Float | 11.61% |
| Short Ratio (days to cover) | 6.94 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -43.26M |
| Pretax Income | -29.60M |
| Net Income | -29.60M |
| EBITDA | -28.88M |
| EBIT | -29.60M |
| Earnings Per Share (EPS) | -$0.75 |
Balance Sheet
The company has $263.28 million in cash and $3.78 million in debt, giving a net cash position of $259.50 million or $6.34 per share.
| Cash & Cash Equivalents | 263.28M |
| Total Debt | 3.78M |
| Net Cash | 259.50M |
| Net Cash Per Share | $6.34 |
| Equity / Book Value | 263.50M |
| Book Value Per Share | 6.43 |
| Working Capital | 261.58M |
Cash Flow
In the last 12 months, operating cash flow was -$20.04 million and capital expenditures -$169,000, giving a free cash flow of -$20.21 million.
| Operating Cash Flow | -20.04M |
| Capital Expenditures | -169,000 |
| Free Cash Flow | -20.21M |
| FCF Per Share | -$0.50 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
THRD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.96% |
| Shareholder Yield | -1.96% |
| Earnings Yield | -5.43% |
| FCF Yield | -3.71% |
Analyst Forecast
The average price target for THRD is $7.00, which is -47.41% lower than the current price. The consensus rating is "Hold".
| Price Target | $7.00 |
| Price Target Difference | -47.41% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |